JP2022546029A5 - - Google Patents
Info
- Publication number
- JP2022546029A5 JP2022546029A5 JP2022512854A JP2022512854A JP2022546029A5 JP 2022546029 A5 JP2022546029 A5 JP 2022546029A5 JP 2022512854 A JP2022512854 A JP 2022512854A JP 2022512854 A JP2022512854 A JP 2022512854A JP 2022546029 A5 JP2022546029 A5 JP 2022546029A5
- Authority
- JP
- Japan
- Prior art keywords
- triazole
- pyran
- methyl
- hydroxymethyl
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019073063 | 2019-08-29 | ||
| EPPCT/EP2019/073063 | 2019-08-29 | ||
| PCT/EP2020/074121 WO2021038068A1 (en) | 2019-08-29 | 2020-08-28 | Alpha-d-galactopyranoside derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546029A JP2022546029A (ja) | 2022-11-02 |
| JP2022546029A5 true JP2022546029A5 (https=) | 2023-09-01 |
| JP7612669B2 JP7612669B2 (ja) | 2025-01-14 |
Family
ID=72561746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512854A Active JP7612669B2 (ja) | 2019-08-29 | 2020-08-28 | アルファ－ｄ－ガラクトピラノシド誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US12319672B2 (https=) |
| EP (1) | EP4021904B1 (https=) |
| JP (1) | JP7612669B2 (https=) |
| KR (1) | KR102824799B1 (https=) |
| CN (1) | CN114585619B (https=) |
| AU (1) | AU2020338816B2 (https=) |
| BR (1) | BR112022003562A2 (https=) |
| CA (1) | CA3148365A1 (https=) |
| ES (1) | ES2972551T3 (https=) |
| HR (1) | HRP20240297T1 (https=) |
| HU (1) | HUE066221T2 (https=) |
| IL (1) | IL290815B2 (https=) |
| MA (1) | MA57000B1 (https=) |
| MX (1) | MX2022002339A (https=) |
| MY (1) | MY207787A (https=) |
| PH (1) | PH12022550436A1 (https=) |
| PL (1) | PL4021904T3 (https=) |
| RS (1) | RS65294B1 (https=) |
| SA (1) | SA522431777B1 (https=) |
| TW (1) | TWI864085B (https=) |
| UA (1) | UA129205C2 (https=) |
| WO (1) | WO2021038068A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114206893A (zh) | 2019-08-09 | 2022-03-18 | 爱杜西亚药品有限公司 | (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物 |
| WO2021028323A1 (en) | 2019-08-09 | 2021-02-18 | Idorsia Pharmaceuticals Ltd | (2-acetamidyl)thio-beta-d-galactopyranoside derivatives |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| US12312362B2 (en) | 2020-10-06 | 2025-05-27 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of Alpha-D-galactopyranosides |
| EP4237419A1 (en) | 2020-11-02 | 2023-09-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives |
| CN116806219A (zh) * | 2021-02-09 | 2023-09-26 | 爱杜西亚药品有限公司 | 羟基杂环烷-氨甲酰基衍生物 |
| RS67032B1 (sr) * | 2021-03-03 | 2025-08-29 | Idorsia Pharmaceuticals Ltd | Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom |
| US20240287121A1 (en) * | 2021-05-28 | 2024-08-29 | Glycomimetics, Inc. | Galectin-3 inhibiting c-glycoside oximes |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100172D0 (sv) | 2001-01-22 | 2001-01-22 | Ulf Nilsson | New inhibitors against galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) * | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| DK2906227T3 (en) | 2012-10-10 | 2018-12-10 | Galectin Therapeutics Inc | GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy |
| CN104755088A (zh) | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| EP2919802A4 (en) | 2012-11-15 | 2016-09-14 | Univ Tufts | METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| PL3456717T3 (pl) | 2015-07-06 | 2021-10-25 | Gilead Sciences, Inc. | Pochodna 4,6-diaminochinolino-3-karbonitrylu jako modulator cot (cancer osaka thyroid) do leczenia choroby zapalnej |
| CA3025867A1 (en) | 2016-07-12 | 2018-01-18 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| EP3621973A4 (en) | 2017-05-12 | 2021-10-27 | Galectin Sciences, LLC | COMPOUNDS FOR THE PREVENTION AND TREATMENT OF DISEASES AND USES THEREOF |
| KR20200015528A (ko) | 2017-05-12 | 2020-02-12 | 갈랙틴 사이언시즈, 엘엘씨 | 전신 인슐린 내성 질환의 치료용 화합물 및 그의 용도 |
| WO2019067702A1 (en) | 2017-09-27 | 2019-04-04 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| US11072626B2 (en) | 2017-10-11 | 2021-07-27 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| CA3080128A1 (en) | 2017-10-31 | 2019-05-09 | Galectin Sciences, Llc | Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof |
| CN113286632A (zh) | 2018-10-15 | 2021-08-20 | 格莱克特生物技术公司 | 半乳糖凝集素的半乳糖苷抑制剂前药 |
| JP2022508720A (ja) | 2018-10-15 | 2022-01-19 | ガレクト バイオテック エービー | ガレクチンのガラクトシド阻害剤 |
| WO2020104335A1 (en) | 2018-11-21 | 2020-05-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| US12269819B2 (en) | 2019-04-10 | 2025-04-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| JP7674276B2 (ja) | 2019-07-03 | 2025-05-09 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
| WO2021004940A1 (en) | 2019-07-05 | 2021-01-14 | Galecto Biotech Ab | Novel galactoside inhibitor of galectins |
| WO2021028323A1 (en) | 2019-08-09 | 2021-02-18 | Idorsia Pharmaceuticals Ltd | (2-acetamidyl)thio-beta-d-galactopyranoside derivatives |
| CN114206893A (zh) | 2019-08-09 | 2022-03-18 | 爱杜西亚药品有限公司 | (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物 |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| US12312362B2 (en) | 2020-10-06 | 2025-05-27 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of Alpha-D-galactopyranosides |
| EP4237419A1 (en) | 2020-11-02 | 2023-09-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1 -carbamoyl derivatives |
| CN116806219A (zh) | 2021-02-09 | 2023-09-26 | 爱杜西亚药品有限公司 | 羟基杂环烷-氨甲酰基衍生物 |
| RS67032B1 (sr) | 2021-03-03 | 2025-08-29 | Idorsia Pharmaceuticals Ltd | Alfa-d-galaktopiranozidni derivati supstituisani triazolil-metilom |
-
2020
- 2020-08-28 CN CN202080060134.6A patent/CN114585619B/zh active Active
- 2020-08-28 PL PL20775188.4T patent/PL4021904T3/pl unknown
- 2020-08-28 PH PH1/2022/550436A patent/PH12022550436A1/en unknown
- 2020-08-28 TW TW109129635A patent/TWI864085B/zh active
- 2020-08-28 KR KR1020227009790A patent/KR102824799B1/ko active Active
- 2020-08-28 EP EP20775188.4A patent/EP4021904B1/en active Active
- 2020-08-28 JP JP2022512854A patent/JP7612669B2/ja active Active
- 2020-08-28 ES ES20775188T patent/ES2972551T3/es active Active
- 2020-08-28 MY MYPI2022001043A patent/MY207787A/en unknown
- 2020-08-28 BR BR112022003562A patent/BR112022003562A2/pt unknown
- 2020-08-28 US US17/638,799 patent/US12319672B2/en active Active
- 2020-08-28 HU HUE20775188A patent/HUE066221T2/hu unknown
- 2020-08-28 HR HRP20240297TT patent/HRP20240297T1/hr unknown
- 2020-08-28 RS RS20240319A patent/RS65294B1/sr unknown
- 2020-08-28 AU AU2020338816A patent/AU2020338816B2/en active Active
- 2020-08-28 WO PCT/EP2020/074121 patent/WO2021038068A1/en not_active Ceased
- 2020-08-28 CA CA3148365A patent/CA3148365A1/en active Pending
- 2020-08-28 UA UAA202201022A patent/UA129205C2/uk unknown
- 2020-08-28 MA MA57000A patent/MA57000B1/fr unknown
- 2020-08-28 MX MX2022002339A patent/MX2022002339A/es unknown
- 2020-08-28 IL IL290815A patent/IL290815B2/en unknown
-
2022
- 2022-02-27 SA SA522431777A patent/SA522431777B1/ar unknown
-
2025
- 2025-04-29 US US19/193,332 patent/US20250257056A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022546029A5 (https=) | ||
| HRP20240297T1 (hr) | Derivati alfa-d-galaktopiranozida | |
| JP2022534261A5 (https=) | ||
| HRP20230388T1 (hr) | Inhibitori oksazin monoacilglicerol lipaze (magl) | |
| JP2024506182A5 (https=) | ||
| US11713312B2 (en) | Substituted bicyclic compounds as farnesoid X receptor modulators | |
| JP2023545046A5 (https=) | ||
| JP2023506642A5 (https=) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| JP2022543666A5 (https=) | ||
| JP2018530591A5 (https=) | ||
| US9511073B2 (en) | Aromatic amides and uses thereof | |
| IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| JP2022552655A5 (https=) | ||
| RU2016137674A (ru) | Производные пиперидиндиона | |
| RU2011116226A (ru) | Пиразолопиридиновые производные как ингибиторы надфн-оксидазы | |
| JP2024509421A5 (https=) | ||
| JP2023525762A5 (https=) | ||
| JP2010540462A5 (https=) | ||
| RU2019117556A (ru) | Индазольные производные, пригодные в качестве ингибиторов диацилглицерид o-ацилтрансферазы 2 | |
| RU2018104868A (ru) | 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1 | |
| JP2020502058A5 (https=) | ||
| JP2014523400A5 (https=) | ||
| JP2021514963A5 (https=) | ||
| IL276624B1 (en) | Triazine derivatives for the treatment of neurotrophin-related diseases |